Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis

STATUS

Recruiting
days left to enroll

33
participants needed

160
sponsor

Milton S. Hershey Medical Center

Send

Updated on 11 May 2022

See if I qualify

analgesic

endometriosis

surgical diagnosis

norethindrone acetate

Summary

The purpose of this study is to determine if the addition of Low Dose Naltrexone to standard endometriosis treatments will improve patient reported endometriosis associated pain.

Description

The central hypothesis of the research study is that low dose naltrexone (LDN), in combination with hormonal suppression of endometriosis (standard of care), will lead to significant improvement of endometriosis-related pain.

The proposal seeks to:

determine if the addition of LDN to standard endometriosis treatments will improve patient- reported endometriosis associated pain using daily Visual Analogue Scale (VAS) scores and
measure the impact of treatment on quality of life as measured by validated questionnaires including the Endometriosis Health Profile-30 (EHP30) and the Patient's Global Impression of Change (PGIC).

Details

Condition	Endometriosis
Treatment	Placebo, naltrexone, Norethindrone acetate
Clinical Study Identifier	NCT03970330
Sponsor	Milton S. Hershey Medical Center
Last Modified on	11 May 2022

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Premenopausal female ages 18 to 45 years old on the day of signing informed consent
	Must agree to use only study-specific analgesic medications during the study and is not known to be intolerant to them
	Diagnosed with endometriosis and has had, within the last 10 years prior to signing the informed consent, surgical diagnosis with direct visualization and/or histopathologic confirmation of endometriosis
	Is not expected to undergo gynecological surgery or other surgical procedures for treatment of endometriosis during the study period
	Agrees to use contraception if not surgically sterile during the entire study
	Patients using oral contraceptives, LARCs and/or GnRH agonists/antagonists for contraception and/or management of endometriosis, with a stable regimen, will be able to continue in the study, however, women using oral contraceptives and GnRH agonist/antagonists will be switched to Norethindrone acetate during the 1-2 week run-in period as prescribed by principle investigator
Exclusion Criteria
	Women that are pregnant, breastfeeding or trying to conceive
	Patients with chronic daily narcotic use and any chronic pain or frequently reoccurring pain condition, other than endometriosis, that is treated with opioids or requires analgesics for more than 7 days per month
	Patients with abnormal liver function tests (greater than 3x normal limit) in the past year or history of liver disease. Routine screening of liver function is not required
	Non-English speaking or inability to read and understand English secondary, in part, to the need to read and report daily results in English
	Undiagnosed vaginal bleeding
	Patients with history of opioid, illicit drug or alcohol abuse
	Patients currently taking thioridazine
	Patients with a history of suicidality
	Patients with current or history of unstable depression or other psychiatric disorder who, by PI judgement, are unstable or not well controlled
	Known, suspected or history of cancer of the breast
	Active deep vein thrombosis, pulmonary embolism or history of these conditions
	Active or recent arterial thromboembolic disease (e.g., stroke, myocardial infarction)

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

analgesic

endometriosis

surgical diagnosis

norethindrone acetate

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Study Definition

Wikipedia

Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis